Thomas D'Alonzo is President at SALIX PHARMACEUTICALS LTD (SLXP). They have made 8 open-market trades across 1 company since 2006, most recently 2015-04-01.
CIK 0001212667
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $143K since 2006, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SLXP | 95,587 | — |
Shares reported on the most recent Form 4, priced at the 2015-02-04 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLXP | SELL · 10b5-1 | 2014-04-22 | 2014-04-24 | $110.89 | $1.3M | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2014-01-10 | 2014-01-14 | $91.83 | $1.1M | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2013-04-08 | 2013-04-10 | $49.57 | $307K | N/A | N/A | N/A |
| SLXP | SELL | 2012-06-08 | 2012-06-12 | $51.63 | $493K | N/A | N/A | N/A |
| SLXP | SELL | 2011-12-06 | 2011-12-08 | $44.43 | $209K | N/A | N/A | N/A |
| SLXP | BUY | 2011-08-11 | 2011-08-11 | $29.72 | $21K | N/A | N/A | N/A |
| SLXP | BUY | 2010-12-01 | 2010-12-03 | $44.80 | $22K | N/A | N/A | N/A |
| SLXP | BUY | 2010-10-07 | 2010-10-12 | $38.00 | $10K | N/A | N/A | N/A |
| SLXP | SELL | 2009-05-11 | 2009-05-13 | $10.09 | $227K | N/A | N/A | N/A |
| SLXP | SELL | 2007-07-03 | 2007-07-06 | $12.30 | $38K | N/A | N/A | N/A |
| SLXP | BUY | 2006-05-08 | 2006-05-10 | $13.01 | $90K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.